- Possibilities of correction of menopausal disorders in women with the use of medicine Menopace
Possibilities of correction of menopausal disorders in women with the use of medicine Menopace
HEALTH OF WOMAN. 2016.5(111):95–100; doi 10.15574/HW.2016.111.95
Possibilities of correction of menopausal disorders in women with the use of medicine Menopace
Reznichenko G. I., Reznichenko N. Yu., Potebnya V. Yu., Kovalenko K. I., Onischenko R. A.
SI «Zaporozhzhia medical Academy of postgraduate education Ministry of health of Ukraine»
The objective: to determine the efficacy of medicine «Menopace» in treatment of women with natural and surgical menopause.
Patients and methods. 20 women (I group) with a natural menopause were examined (basic subgroup consisted of 10 patients who used Menopace for 3 months; control subgroup consisted of 10 patients). 20 women (II group) with surgical menopause were examined (basic subgroup consisted of 10 patients who received Menopace for 3 months; control subgroup consisted of 10 patients).
Results. The average score of neurovegetative and emotional manifestations of climacteric syndrome during the observation period decreased in women with natural and surgical menopause who used Menopace, compared with subgroups of patients who had not used the medicine.
Conclusions. 1. The use of the medicine Menopace in women with natural menopause after 3 months showed the disappearance of clinical symptoms of climacteric syndrome in 70% of the cases, and significant improvement in general condition in 30% of cases.
2. During surgical menopause after 1 month of treatment with Menopace manifestations of sweating were observed 4.5 times less often than in control group, tides were observed 7 times less often than in control group. Neurovegetative and psychoemotional symptoms of menopause were absent in 80% of women after 3 months of treatment and in 20% of cases significant improvement was shown.
3. The obtained results give grounds to recommend wide use of Menopace in practical work for the treatment of menopausal syndrome during natural and surgical menopause.
Key words: menopause, therapy, Menopace.
REFERENCES
1. Vedenie zhenschin v peri- i postmenopauze: prakticheskie rekomendatsii. Pod red. VP Smetnik, LM Ilinoy. Yaroslavl, OOO «IPK «Litera». 2010:221.
2. Vihlyaeva EM. 2008. Postmenopauzalnaya terapiya. M, MEDpress-inform:447.
3. Levakov SA, Kedrova AG, Vanke NS. 2011. Klinicheskie printsipyi korrektsii rannih narusheniy hirurgicheskoy i estestvennoy menopauzyi. Posobie dlya vrachey. M:44.
4. Lihachev VK. 2007. Prakticheskaya ginekologiya: Rukovodstvo dlya vrachey. M, OOO «Meditsinskoe informatsionnoe agentstvo»:664.
5. Reznichenko NIu, Reznichenko YuH, Reznichenko HI. 2013. Vitaminoprofilaktyka ta vitaminoterapiia meshkantsiv promyslovykh tsentriv. K, «Liudoprynt Ukraina»:108.
6. Tatarchuk TF, Zaharenko NF, Manolyak IP. 2014. Osobennosti proyavleniya klimaktericheskogo sindroma u zhenschin s endometriozom i vozmozhnyie puti ego korrektsii. Naukoviy zhurnal MOZ UkraYini 2(6):71–78.
7. Tatarchuk TF, Islamova AO, Efimenko OA. 2015. Klimaktericheskiy sindrom kak pervoe klinicheskoe proyavlenie menopauzyi. Reproduktivna endokrinologIya 1(21):52–545.
8. Cagnacci A, Cannoletta M, Palma F et al. 2012. Menopausal symptoms and risk factors for cardiovascular disease in postmenopause. J. Climacteric. 15:157–162. http://dx.doi.org/10.3109/13697137.2011.617852; PMid:22141325
9. De Villiers TJ, Gass ML, Haines CJ et al. 2013. Global Consensus Statement on Menopausal Hormone Therapy. Climacteric. 16:203–4. http://dx.doi.org/10.3109/13697137.2013.771520; PMid:23488524
10. Matsui S, Yasui T, Tani A et al. 2014. Effect of ultra-low-dose estradiol and dydrogesterone on arterial stiffness in postmenopausal women. J. Climacteric. 17:191–196. http://dx.doi.org/10.3109/13697137.2013.856399; PMid:24164272
11. Archer DF, Schmelter Th, Schaefers M et al. 2014. A randomized, double-blind, placebo-controlled study of the lowest effective dose of drospirenone with 17b-estradiol for moderate to severe vasomotor symptoms in postmenopausal women. Menopause 21(3):227–235. http://dx.doi.org/10.1097/GME.0b013e31829c1431; PMid:23963307
12. Practice Bulletin No.141: Management of Menopausal Symptoms. ObstetGynecol. 2014. 123:202–216. http://dx.doi.org/10.1097/01.AOG.0000441353.20693.78; PMid:24463691
13. Whelan AM, Jurgens TM, Naylor H. 2009. Herbs, vitamins and minerals in the treatment of premenstrual syndrome: a systematic review. Can. J. Clin. Pharmacol. 16(3):407–29.